BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

197 related articles for article (PubMed ID: 35217669)

  • 1. The E3 ubiquitin-protein ligase Trim31 alleviates non-alcoholic fatty liver disease by targeting Rhbdf2 in mouse hepatocytes.
    Xu M; Tan J; Dong W; Zou B; Teng X; Zhu L; Ge C; Dai X; Kuang Q; Zhong S; Lai L; Yi C; Tang T; Zhao J; Wang L; Liu J; Wei H; Sun Y; Yang Q; Li Q; Lou D; Hu L; Liu X; Kuang G; Luo J; Xiong M; Feng J; Zhang C; Wang B
    Nat Commun; 2022 Feb; 13(1):1052. PubMed ID: 35217669
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Tripartite motif-containing protein 31 confers protection against nonalcoholic steatohepatitis by deactivating mitogen-activated protein kinase kinase kinase 7.
    Xu MX; Tan J; Ge CX; Dong W; Zhang LT; Zhu LC; Zhao JJ; Wang LY; Liu J; Wei H; Sun Y; Dai XL; Kuang Q; Li YL; Li H; Liu JY; Zou L; Liang RR; Zhang CF; Xu J; Wang BC
    Hepatology; 2023 Jan; 77(1):124-143. PubMed ID: 35429173
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Palmitoyltransferase ZDHHC3 Aggravates Nonalcoholic Steatohepatitis by Targeting S-Palmitoylated IRHOM2.
    Xu M; Tan J; Zhu L; Ge C; Zhang Y; Gao F; Dai X; Kuang Q; Chai J; Zou B; Wang B
    Adv Sci (Weinh); 2023 Oct; 10(28):e2302130. PubMed ID: 37544908
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Tripartite motif 38 alleviates the pathological process of NAFLD-NASH by promoting TAB2 degradation.
    Yao X; Dong R; Hu S; Liu Z; Cui J; Hu F; Cheng X; Wang X; Ma T; Tian S; Zhang XJ; Hu Y; Bai L; Li H; Zhang P
    J Lipid Res; 2023 Jul; 64(7):100382. PubMed ID: 37116711
    [TBL] [Abstract][Full Text] [Related]  

  • 5. The E3 ubiquitin ligase TRIM31 plays a critical role in hypertensive nephropathy by promoting proteasomal degradation of MAP3K7 in the TGF-β1 signaling pathway.
    Zhang J; Cao L; Wang X; Li Q; Zhang M; Cheng C; Yu L; Xue F; Sui W; Sun S; Li N; Bu P; Liu B; Gao F; Zhen J; Su G; Zhang C; Gao C; Zhang M; Zhang Y
    Cell Death Differ; 2022 Mar; 29(3):556-567. PubMed ID: 34584221
    [TBL] [Abstract][Full Text] [Related]  

  • 6. TRIB3-TRIM8 complex drives NAFLD progression by regulating HNF4α stability.
    Xiao MC; Jiang N; Chen LL; Liu F; Liu SQ; Ding CH; Wu SH; Wang KQ; Luo YY; Peng Y; Yan FZ; Zhang X; Qian H; Xie WF
    J Hepatol; 2024 May; 80(5):778-791. PubMed ID: 38237865
    [TBL] [Abstract][Full Text] [Related]  

  • 7. TRIM31 is upregulated in hepatocellular carcinoma and promotes disease progression by inducing ubiquitination of TSC1-TSC2 complex.
    Guo P; Ma X; Zhao W; Huai W; Li T; Qiu Y; Zhang Y; Han L
    Oncogene; 2018 Jan; 37(4):478-488. PubMed ID: 28967907
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Tmbim1 is a multivesicular body regulator that protects against non-alcoholic fatty liver disease in mice and monkeys by targeting the lysosomal degradation of Tlr4.
    Zhao GN; Zhang P; Gong J; Zhang XJ; Wang PX; Yin M; Jiang Z; Shen LJ; Ji YX; Tong J; Wang Y; Wei QF; Wang Y; Zhu XY; Zhang X; Fang J; Xie Q; She ZG; Wang Z; Huang Z; Li H
    Nat Med; 2017 Jun; 23(6):742-752. PubMed ID: 28481357
    [TBL] [Abstract][Full Text] [Related]  

  • 9. The melanoma-associated antigen 1 (MAGEA1) protein stimulates the E3 ubiquitin-ligase activity of TRIM31 within a TRIM31-MAGEA1-NSE4 complex.
    Kozakova L; Vondrova L; Stejskal K; Charalabous P; Kolesar P; Lehmann AR; Uldrijan S; Sanderson CM; Zdrahal Z; Palecek JJ
    Cell Cycle; 2015; 14(6):920-30. PubMed ID: 25590999
    [TBL] [Abstract][Full Text] [Related]  

  • 10. TNFAIP3 Interacting Protein 3 Overexpression Suppresses Nonalcoholic Steatohepatitis by Blocking TAK1 Activation.
    Liu D; Zhang P; Zhou J; Liao R; Che Y; Gao MM; Sun J; Cai J; Cheng X; Huang Y; Chen G; Nie H; Ji YX; Zhang XJ; Huang Z; Xu H; She ZG; Li H
    Cell Metab; 2020 Apr; 31(4):726-740.e8. PubMed ID: 32268115
    [TBL] [Abstract][Full Text] [Related]  

  • 11. The E3 Ubiquitin Ligase Ring Finger Protein 5 Ameliorates NASH Through Ubiquitin-Mediated Degradation of 3-Hydroxy-3-Methylglutaryl CoA Reductase Degradation Protein 1.
    Yang Q; Chen X; Zhang Y; Hu S; Hu F; Huang Y; Ma T; Hu H; Tian H; Tian S; Ji YX; She ZG; Zhang P; Zhang XJ; Hu Y; Yang H; Yuan Y; Li H
    Hepatology; 2021 Dec; 74(6):3018-3036. PubMed ID: 34272738
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Loss of TRIM31 promotes breast cancer progression through regulating K48- and K63-linked ubiquitination of p53.
    Guo Y; Li Q; Zhao G; Zhang J; Yuan H; Feng T; Ou D; Gu R; Li S; Li K; Lin P
    Cell Death Dis; 2021 Oct; 12(10):945. PubMed ID: 34650049
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Tripartite motif 16 ameliorates nonalcoholic steatohepatitis by promoting the degradation of phospho-TAK1.
    Wang L; Zhang X; Lin ZB; Yang PJ; Xu H; Duan JL; Ruan B; Song P; Liu JJ; Yue ZS; Fang ZQ; Hu H; Liu Z; Huang XL; Yang L; Tian S; Tao KS; Han H; Dou KF
    Cell Metab; 2021 Jul; 33(7):1372-1388.e7. PubMed ID: 34146477
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Ubiquitination of cytoplasmic HMGB1 by RNF186 regulates hepatic lipophagy in non-alcoholic fatty liver disease.
    Du J; Ji X; Xu B; Du Q; Li Y; Zhou B; Liu X; Xu Z; Jiang Y; Kou B; Li Z; Cui C; Lin J
    Metabolism; 2024 Mar; 152():155769. PubMed ID: 38158076
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Nickel chloride promotes lung cancer invasion and metastasis by up-regulating the expression of E3 ubiquitin ligase TRIM31 through the IL-6/STAT3 signaling axis.
    Lu Y; Su F; Cheng Z; Yang J; Dai H; Yang J; Zhang T; Bai Y
    Life Sci; 2023 Nov; 332():122111. PubMed ID: 37734436
    [TBL] [Abstract][Full Text] [Related]  

  • 16. The E3 ubiquitin ligase TRIM31 is involved in cerebral ischemic injury by promoting degradation of TIGAR.
    Zeng S; Zhao Z; Zheng S; Wu M; Song X; Li Y; Zheng Y; Liu B; Chen L; Gao C; Liu H
    Redox Biol; 2021 Sep; 45():102058. PubMed ID: 34218200
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Targeted Delivery of Stk25 Antisense Oligonucleotides to Hepatocytes Protects Mice Against Nonalcoholic Fatty Liver Disease.
    Cansby E; Nuñez-Durán E; Magnusson E; Amrutkar M; Booten SL; Kulkarni NM; Svensson LT; Borén J; Marschall HU; Aghajan M; Mahlapuu M
    Cell Mol Gastroenterol Hepatol; 2019; 7(3):597-618. PubMed ID: 30576769
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Inhibition of receptor-interacting protein kinase 1 improves experimental non-alcoholic fatty liver disease.
    Majdi A; Aoudjehane L; Ratziu V; Islam T; Afonso MB; Conti F; Mestiri T; Lagouge M; Foufelle F; Ballenghien F; Ledent T; Moldes M; Cadoret A; Fouassier L; Delaunay JL; Aït-Slimane T; Courtois G; Fève B; Scatton O; Prip-Buus C; Rodrigues CMP; Housset C; Gautheron J
    J Hepatol; 2020 Apr; 72(4):627-635. PubMed ID: 31760070
    [TBL] [Abstract][Full Text] [Related]  

  • 19. TRIM31 promotes apoptosis via TAK1-mediated activation of NF-κB signaling in sepsis-induced myocardial dysfunction.
    Yang X; Sun J; Sun F; Yao Y; Tian T; Zhou J; Shen W; Lu M; Lei M
    Cell Cycle; 2020 Oct; 19(20):2685-2700. PubMed ID: 33016203
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Hepatocyte SH3RF2 Deficiency Is a Key Aggravator for NAFLD.
    Yang X; Sun D; Xiang H; Wang S; Huang Y; Li L; Cheng X; Liu H; Hu F; Cheng Y; Ma T; Hu M; Tian H; Tian S; Zhou Y; Zhang P; Zhang XJ; Ji YX; Hu Y; Li H; She ZG
    Hepatology; 2021 Sep; 74(3):1319-1338. PubMed ID: 33894019
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 10.